483 Document: Neelakantan Anand, MD, Oct 24, 2019

FDANews 483 Neelakantan Anand, MD Oct 24 2019 top
Mark W. Babbitt FDA Investigator

On Oct 24, 2019, the FDA inspected Neelakantan Anand, MD's Los Angeles site. Explore the inspectional observations.